Jamieson Wellness Inc (JWEL) AI Stock Analysis

• Market Cap: C$1.49B
• Dividend Yield: 3.23%
• Average Volume (3M): 49.00K
• Price to Earnings (P/E): 27.8
• Beta (1Y): 0.93
• Revenue Growth: 12.62%
• EPS Growth: 47.37%
• Country: CA
• Employees: 891
• Sector: Healthcare
• Sector Strength: 44
• Industry: Packaged Foods
• EPS (TTM): 0.14
• Shares Outstanding: 41,685,783
• 10 Day Avg. Volume: 39,895
• 30 Day Avg. Volume: 48,997
• PEG Ratio: -35.42
• Price to Book (P/B): 3.33
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 39.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$42.25
• Price Target Upside: 18.41% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 76 Outperform
• Price Target: C$40.00 ▲(12.11%Upside)

Jamieson Wellness Inc. demonstrates robust financial performance and bullish technical indicators, supporting a strong stock score. The premium valuation suggests high market expectations, while positive corporate events further bolster investor confidence.

Positive Factors

Market Opportunities

The U.S. and China markets present significant growth opportunities for Jamieson Wellness, supported by ongoing growth in Canada and International markets.

Revenue Growth

Jamieson Wellness is expected to reach its long-term revenue target of over $1 billion, driven mainly by the Jamieson Brands segment across all major geographies, supported by secular tailwinds.

Negative Factors

Revenue Performance

Revenue was slightly below forecast in Canada, but China was above forecast, showing strong growth.

Jamieson Wellness Inc Business Overview & Revenue Model

Company Description

Jamieson Wellness Inc (JWEL) is a leading health and wellness company based in Canada. The company operates in the consumer health sector, primarily focusing on the development, manufacturing, and distribution of a wide range of vitamins, minerals, and supplements. Its core products are designed to promote health and wellness, with a strong emphasis on quality and efficacy. Jamieson Wellness is known for its flagship brand, Jamieson, which is one of Canada's most recognized and trusted vitamin brands.

How the Company Makes Money

Jamieson Wellness Inc generates revenue through the sale of its health and wellness products, which include vitamins, minerals, and supplements. These products are distributed through multiple channels, including retail stores, e-commerce platforms, and direct-to-consumer sales. The company benefits from its well-established brand reputation and wide distribution network, which spans both domestic and international markets. Key revenue streams include sales from its flagship Jamieson brand as well as other owned brands like Progressive, Smart Solutions, and Iron Vegan. Additionally, Jamieson Wellness engages in strategic partnerships and collaborations with retailers and distributors to enhance its market presence and drive sales growth.

Jamieson Wellness Inc Financial Statement Overview

Summary

Jamieson Wellness Inc. exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet shows moderate leverage, but the overall financial health remains stable.

Income Statement

Jamieson Wellness Inc. demonstrates strong income statement performance with consistent revenue growth, evidenced by a TTM revenue increase. The gross profit margin has remained healthy, and net profit margins are stable, indicating effective cost management. The EBIT and EBITDA margins show solid operational efficiency, supporting profitability.

Balance Sheet

The company's balance sheet reflects moderate leverage with a reasonable debt-to-equity ratio, suggesting managed financial risk. The equity ratio indicates a solid proportion of assets funded by shareholders, enhancing financial stability. However, some caution is warranted due to the rise in total liabilities over the periods.

Cash Flow

Jamieson Wellness Inc. has shown robust cash flow performance with a significant increase in free cash flow, indicating strong cash generation capability. The operating cash flow to net income ratio is favorable, demonstrating efficient cash conversion. However, the company should monitor capital expenditures closely to sustain free cash flow growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	751.71M	733.78M	676.17M	547.37M	451.03M	403.66M
Gross Profit	288.05M	275.61M	233.56M	198.34M	162.44M	144.76M
EBITDA	117.32M	114.60M	108.78M	100.17M	90.40M	75.30M
Net Income	53.58M	51.91M	47.88M	52.81M	52.08M	41.60M
Balance Sheet
Total Assets	1.13B	1.21B	1.14B	1.11B	652.48M	609.34M
Cash, Cash Equivalents and Short-Term Investments	41.11M	44.79M	36.86M	26.24M	6.78M	1.17M
Total Debt	295.00M	308.29M	462.99M	400.00M	149.13M	149.06M
Total Liabilities	602.28M	660.41M	662.38M	675.67M	310.45M	316.94M
Stockholders Equity	485.26M	505.18M	438.93M	431.59M	342.02M	292.40M
Cash Flow
Free Cash Flow	89.69M	51.41M	22.41M	36.02M	22.12M	27.43M
Operating Cash Flow	100.43M	61.58M	31.71M	50.59M	44.41M	40.60M
Investing Cash Flow	-10.74M	-10.16M	-35.13M	-256.53M	-22.28M	-13.17M
Financing Cash Flow	-84.07M	-45.43M	14.04M	225.41M	-16.51M	-26.46M

Jamieson Wellness Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 35.68
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JWEL, the sentiment is Positive. The current price of 35.68 is below the 20-day moving average (MA) of 36.06, above the 50-day MA of 34.19, and above the 200-day MA of 33.40, indicating a neutral trend. The MACD of 0.34 indicates Positive momentum. The RSI at 53.05 is Neutral, neither overbought nor oversold. The STOCH value of 20.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:JWEL.

Jamieson Wellness Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JWEL	76 Outperform	C$1.49B	27.77	11.64%	3.23%	12.62%	47.37%
Sector *	65 Neutral	¥345.58B	10.59	-2.88%	2.65%	11.80%	-6.84%
BABY	46 Neutral	$6.81M	―	-351.09%	―	-5.13%	20.54%
NPRA	37 Underperform	C$8.88M	―	162.13%	―	-5.97%	63.24%
CULT	33 Underperform	C$1.87M	―	-185.93%	―	―	48.34%
PNGA	27 Underperform	C$4.04M	―		―	-97.30%	39.70%

Jamieson Wellness Inc Corporate Events

Jamieson Wellness Inc. Reports Successful Election of Directors at 2025 Shareholder Meeting

Jamieson Wellness Inc. announced the successful election of its nominee directors at the 2025 Annual Meeting of Shareholders, with all directors receiving overwhelming support. This development underscores the company’s stable governance and continued focus on expanding its market presence in the natural health industry.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Redeems Series A Preference Shares, Strengthens China Market Position

Jamieson Wellness Inc. announced the redemption of its Series A Preference Shares held by DCP Capital Partners, reflecting a strategic financial move aligned with DCP’s investment cycle. This redemption underscores the successful partnership between Jamieson and DCP, which has significantly bolstered Jamieson’s presence in China’s VMS market, contributing to substantial growth and positioning the company for continued success in this critical market.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Inc. Reports Strong Q1 2025 Results with 14% Revenue Growth

Jamieson Wellness Inc. reported a strong start to 2025 with a 14% increase in consolidated revenue for the first quarter, driven by significant growth in China and strategic initiatives in Canada and international markets. The company’s strategic focus on innovation, operational efficiency, and expanding market reach has resulted in increased gross profit margins and improved financial performance, despite a net loss. The growth in China was particularly notable, with a 52% revenue increase, highlighting the success of their tailored approach and strategic investments in the region.

Jamieson Wellness to Announce Q1 2025 Financial Results

Jamieson Wellness Inc. announced it will release its first quarter 2025 financial results on May 8, 2025, followed by a conference call for investors. This announcement is significant for stakeholders as it provides an opportunity to assess the company’s financial health and strategic direction, potentially impacting its market positioning and investor confidence.